Profile
Aldo R.
Baumgartner served as President & Chief Executive Officer at Hoffmann-La Roche, Inc. from 1981 to 1988.
He then served as President & Chief Executive Officer at Wyeth Ayerst Canada, Inc. from 1992 to 2003.
From 2005 to 2012, he was a Director at Osta Biotechnologies, Inc. Prior to that, he served as President & General Manager-Belgian Operations at Hoffmann-La Roche, Inc. and as a Member-Management Board at Canadian Institutes of Health Research.
Baumgartner holds a doctorate degree from the University of Geneva.
Former positions of Aldo R. Baumgartner
| Companies | Position | End |
|---|---|---|
Osta Biotechnologies, Inc.
 Osta Biotechnologies, Inc. BiotechnologyHealth Technology Osta Biotechnologies, Inc. was a life sciences firm that focused on the development of novel therapeutic products for cancer and alzheimer's disease. The company has also developed a pipe line of novel diagnostic and therapeutic products for alzheimer's disease, osteoporosis, osteoarthritis and xlinked hypophosphatemic rickets. Osta Biotechnologies was founded by Ajay Gupta and Andrew Karaplis on January 9, 2004 and is headquartered in Dollard-des-Ormeaux, Canada. | Director/Board Member | 23/01/2012 |
| Wyeth Ayerst Canada, Inc. | President | 01/02/2003 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | President | 01/01/1988 |
Canadian Institutes of Health Research
 Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Training of Aldo R. Baumgartner
| University of Geneva | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Osta Biotechnologies, Inc.
Osta Biotechnologies, Inc. BiotechnologyHealth Technology Osta Biotechnologies, Inc. was a life sciences firm that focused on the development of novel therapeutic products for cancer and alzheimer's disease. The company has also developed a pipe line of novel diagnostic and therapeutic products for alzheimer's disease, osteoporosis, osteoarthritis and xlinked hypophosphatemic rickets. Osta Biotechnologies was founded by Ajay Gupta and Andrew Karaplis on January 9, 2004 and is headquartered in Dollard-des-Ormeaux, Canada. | Health Technology |
| Wyeth Ayerst Canada, Inc. | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Canadian Institutes of Health Research
Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | Commercial Services |
- Stock Market
- Insiders
- Aldo R. Baumgartner
